| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.
Over the last 12 months, insiders at Estrella Immunopharma, Inc. have bought $0 and sold $0 worth of Estrella Immunopharma, Inc. stock.
On average, over the past 5 years, insiders at Estrella Immunopharma, Inc. have bought $44.68B and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 141,970 shares for transaction amount of $44.68B was made by Li Jianwei (Co‑Chief Executive Officer) on 2022‑03‑04.
| Increased Positions | 14 | +175% | 357,595 | +48.12% |
| Decreased Positions | 3 | -37.5% | 51,176 | -6.89% |
| New Positions | 6 | New | 131,779 | New |
| Sold Out Positions | 2 | Sold Out | 4,016 | Sold Out |
| Total Postitions | 19 | +137.5% | 1M | +41.23% |
| Vanguard Group Inc | $583.00 | 1.11% | 419,711 | +136,868 | +48.39% | 2025-09-30 |
| Geode Capital Management, Llc | $141.00 | 0.27% | 101,490 | -1,847 | -1.79% | 2025-09-30 |
| Ubs Group Ag | $70.00 | 0.13% | 50,347 | -22,426 | -30.82% | 2025-09-30 |
| Citadel Advisors Llc | $70.00 | 0.13% | 50,122 | -34 | -0.07% | 2025-09-30 |
| Atw Spac Management Llc | $56.00 | 0.11% | 40,000 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $33.00 | 0.06% | 24,084 | -7,323 | -23.32% | 2025-09-30 |
| State Street Corp | $31.00 | 0.06% | 22,352 | 0 | 0% | 2025-09-30 |
| Renaissance Technologies Llc | $15.00 | 0.03% | 10,689 | +10,689 | New | 2025-09-30 |
| Xtx Topco Ltd | $14.00 | 0.03% | 10,373 | +10,373 | New | 2025-09-30 |
| Maso Capital Partners Ltd | $14.00 | 0.03% | 10,000 | 0 | 0% | 2025-09-30 |